Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 35.37 USD -4.22% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Verona Pharma PLC
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Verona Pharma PLC
Total Current Liabilities Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Total Current Liabilities
$28m
CAGR 3-Years
0%
CAGR 5-Years
13%
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Total Current Liabilities
ÂŁ20.3B
CAGR 3-Years
-2%
CAGR 5-Years
-5%
CAGR 10-Years
5%
AstraZeneca PLC
LSE:AZN
Total Current Liabilities
$28.6B
CAGR 3-Years
9%
CAGR 5-Years
12%
CAGR 10-Years
6%
Indivior PLC
LSE:INDV
Total Current Liabilities
$1B
CAGR 3-Years
17%
CAGR 5-Years
9%
CAGR 10-Years
8%
Hikma Pharmaceuticals PLC
LSE:HIK
Total Current Liabilities
$1.4B
CAGR 3-Years
13%
CAGR 5-Years
1%
CAGR 10-Years
9%
Dechra Pharmaceuticals PLC
LSE:DPH
Total Current Liabilities
ÂŁ164m
CAGR 3-Years
6%
CAGR 5-Years
12%
CAGR 10-Years
5%

See Also

What is Verona Pharma PLC's Total Current Liabilities?
Total Current Liabilities
28m USD

Based on the financial report for Sep 30, 2024, Verona Pharma PLC's Total Current Liabilities amounts to 28m USD.

What is Verona Pharma PLC's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
13%

Over the last year, the Total Current Liabilities growth was 210%.

Back to Top